NASDAQ •
Healthcare •
Biotechnology •
Quote as of 09/10/2026 15:25
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization57,987 mln
Float327 mln
Earnings Date10/29/2026
Piotroski F-Score
1
/ 9
Very weak
Beneish M-Score
-3.83
Highly reliable
1-Year Forecast
116
Limited downside
Relative Strength
16
/ 100
Significantly lagging
Debt / Equity
0.19
Very low leverage
Pre-Tax Margin
-140%
Severely loss-making
Business Description
Moderna is a biotechnology company founded in 2010 and based in Cambridge, Massachusetts, that develops medicines using messenger RNA technology. Its work spans a broad range of health challenges, including vaccines for respiratory illnesses, viral infections, and bacterial diseases, as well as treatments for certain cancers and rare genetic conditions. The company works alongside notable partners such as Merck, Vertex Pharmaceuticals, the Bill & Melinda Gates Foundation, and OpenAI to advance its research and bring new treatments to patients across the United States and around the world.
